ClinConnect ClinConnect Logo
Search / Trial NCT05470023

Imaging-based Assessment of Oral Biofilm and Gingival Health

Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Jul 19, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at new ways to measure and improve the health of your mouth, specifically focusing on plaque buildup and gum health. Researchers will take photographs and use imaging software to assess how well your mouth is doing. They will also explore how different toothpastes and mouthwashes can affect your oral health. If you decide to participate, you will use a specific toothpaste or mouthwash for a period of 7 days to 6 months, and the researchers will check your plaque levels, gum health, and saliva production through exams and photos.

To join this study, you should be at least 18 years old and in good overall health. However, if you have had allergies or bad reactions to oral hygiene products like toothpastes or mouthwashes, you won't be eligible. This trial is open to everyone, regardless of gender, and aims to find better methods to assess mouth health and see if certain products can help improve gum conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • At least 18 years of age or older
  • In good general health
  • Exclusion Criteria:
  • History of allergy or intolerance of oral hygiene products such as toothpastes and mouthrinses

About University Of California, Irvine

The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.

Locations

Irvine, California, United States

Patients applied

0 patients applied

Trial Officials

Dr. Petra Wilder-Smith

Principal Investigator

Beckman Laser Institute University of California Irvine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials